Bioven to List Cuban Cancer Drug
CimaVax-EGF, the lung cancer vaccine developed by Cuba’s Center of Molecular Immunology is the very first therapeutic cancer vaccine. It targets non-small-cell lung carcinoma, the most common form of lung cancer. The CimaVax-EGF discovery was the result of ... More »